{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:46:39Z","timestamp":1769723199155,"version":"3.49.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771264"],"award-info":[{"award-number":["31771264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822002"],"award-info":[{"award-number":["81822002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170273"],"award-info":[{"award-number":["82170273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Atherosclerosis has been the main cause of disability and mortality in the world, resulting in a heavy medical burden for all countries. It is widely known to be a kind of chronic inflammatory disease in the blood walls, of which the key pathogenesis is the accumulation of immunologic cells in the lesion, foam cells formation, and eventually plaque rupture causing ischemia of various organs. Non-coding RNAs (ncRNAs) play a vital role in regulating the physiologic and pathophysiologic processes in cells. More and more studies have revealed that ncRNAs also participated in the development of atherosclerosis and regulated cellular phenotypes such as endothelial dysfunction, leukocyte recruitment, foam cells formation, and vascular smooth muscle cells phenotype-switching and apoptosis. Given the broad functions of ncRNAs in atherogenesis, they have become potential therapeutic targets. Apart from that, ncRNAs have become powerful blueprints to design new drugs. For example, RNA interference drugs were inspired by small interfering RNAs that exist in normal cellular physiologic processes and behave as negative regulators of specific proteins. For instance, inclisiran is a kind of RNAi drug targeting PCKS9 mRNA, which can lower the level of LDL-C and treat atherosclerosis. We introduce some recent research progresses on ncRNAs related to atherosclerotic pathophysiologic process and the current clinical trials of RNA drugs pointed at atherosclerosis.<\/jats:p>","DOI":"10.3389\/fcvm.2022.889743","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T06:50:10Z","timestamp":1650869410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-coding RNA-Associated Therapeutic Strategies in Atherosclerosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Yuyan","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00428-002-0605-1","article-title":"Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age","volume":"441","author":"Nakashima","year":"2002","journal-title":"Virchows Arch."},{"key":"B4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/cvr\/cvn099","article-title":"Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans","volume":"79","author":"Nakashima","year":"2008","journal-title":"Cardiovasc Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1073\/pnas.0237367100","article-title":"Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress","volume":"100","author":"de Nigris","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/jcp.26016","article-title":"Low shear stress induces endothelial reactive oxygen species via the AT1R\/eNOS\/NO pathway","volume":"233","author":"Chao","year":"2018","journal-title":"J Cell Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-kappaB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/path.1711710311","article-title":"The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis","volume":"171","author":"Davies","year":"1993","journal-title":"J Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"and Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"regulates macrophage gene expression through ligand activation of PPARgamma","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(00)81575-5","article-title":"PPARgamma promotes monocyte\/macrophage differentiation and uptake of oxidized LDL","volume":"93","author":"Tontonoz","year":"1998","journal-title":"Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1074\/jbc.M113.515890","article-title":"Cellular cholesterol regulates ubiquitination and degradation of the cholesterol export proteins ABCA1 and ABCG1","volume":"289","author":"Hsieh","year":"2014","journal-title":"J Biol Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1172\/JCI33372","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.18632\/aging.102498","article-title":"Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1","volume":"11","author":"Ren","year":"2019","journal-title":"Aging."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.7150\/thno.26193","article-title":"Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARgamma-LXRalpha-ABCA1\/ABCG1 pathway and promotes cholesterol efflux in advanced plaque","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics."},{"key":"B23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/CIRCRESAHA.107.152736","article-title":"Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro","volume":"101","author":"Pidkovka","year":"2007","journal-title":"Circ Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/cvr\/cvy007","article-title":"Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis","volume":"114","author":"Grootaert","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1080\/15548627.2015.1096485","article-title":"Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis","volume":"11","author":"Grootaert","year":"2015","journal-title":"Autophagy."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.115.305896","article-title":"Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype","volume":"35","author":"Gardner","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.aaf6659","article-title":"Senescent intimal foam cells are deleterious at all stages of atherosclerosis","volume":"354","author":"Childs","year":"2016","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0008-6363(98)00311-3","article-title":"Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques","volume":"41","author":"Lutgens","year":"1999","journal-title":"Cardiovasc Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0021-9150(96)06037-6","article-title":"Cell death in human atherosclerotic plaques involves both oncosis and apoptosis","volume":"130","author":"Crisby","year":"1997","journal-title":"Atherosclerosis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur Heart J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.biopha.2017.09.064","article-title":"hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis","volume":"95","author":"Li","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1172\/JCI98230","article-title":"Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN","volume":"129","author":"Hu","year":"2019","journal-title":"J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/ATVBAHA.114.303240","article-title":"Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA","volume":"34","author":"Bell","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1073\/pnas.1810729116","article-title":"SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4","volume":"116","author":"Lyu","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1111\/febs.13515","article-title":"Recent insights into cell death and autophagy","volume":"282","author":"Fitzwalter","year":"2015","journal-title":"FEBS J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41418-018-0235-z","article-title":"The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling","volume":"26","author":"Guo","year":"2019","journal-title":"Cell Death Differ."},{"key":"B42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41419-019-1599-9","article-title":"MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis","volume":"10","author":"Su","year":"2019","journal-title":"Cell Death Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCRESAHA.112.270314","article-title":"IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal","volume":"111","author":"Sun","year":"2012","journal-title":"Circ Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.3487","article-title":"MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1","volume":"20","author":"Schober","year":"2014","journal-title":"Nat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/ATVBAHA.109.196832","article-title":"ANRIL expression is associated with atherosclerosis risk at chromosome 9p21","volume":"30","author":"Holdt","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12265-020-10053-0","article-title":"Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker","volume":"14","author":"Fang","year":"2021","journal-title":"J Cardiovasc Transl Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/CIRCRESAHA.118.314240","article-title":"Circ_Lrp6, a Circular RNA enriched in vascular smooth muscle cells. Acts as a sponge regulating miRNA-145 function","volume":"124","author":"Hall","year":"2019","journal-title":"Circ Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCRESAHA.117.311722","article-title":"Smooth muscle differentiation control comes full circle: the circular noncoding RNA, circActa2, functions as a miRNA sponge to fine-tune alpha-SMA expression","volume":"121","author":"Weiser-Evans","year":"2017","journal-title":"Circ Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/CIRCULATIONAHA.115.021019","article-title":"Smooth muscle enriched long noncoding RNA(SMILR) regulates cell proliferation","volume":"133","author":"Ballantyne","year":"2016","journal-title":"Circulation."},{"key":"B52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.119.314876","article-title":"The human-specific and smooth muscle cell-enriched LncRNA SMILR promotes proliferation by regulating mitotic CENPF mRNA and drives cell-cycle progression which can be targeted to limit vascular remodeling","volume":"125","author":"Mahmoud","year":"2019","journal-title":"Circ Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1161\/CIRCULATIONAHA.121.055949","article-title":"CARMN is an evolutionarily conserved smooth muscle cell-specific LncRNA that maintains contractile phenotype by binding myocardin","volume":"144","author":"Dong","year":"2021","journal-title":"Circulation."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/CIRCRESAHA.120.318688","article-title":"CARMN loss regulates smooth muscle cells and accelerates atherosclerosis in mice","volume":"128","author":"Vacante","year":"2021","journal-title":"Circ Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1161\/ATVBAHA.114.305212","article-title":"MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2","volume":"35","author":"Zhao","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1161\/CIRCULATIONAHA.117.027799","article-title":"miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation","volume":"137","author":"Yang","year":"2018","journal-title":"Circulation."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.120.316489","article-title":"miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases","volume":"126","author":"Farina","year":"2020","journal-title":"Circ Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature."},{"key":"B59","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1161\/CIRCULATIONAHA.111.084186","article-title":"MicroRNA-145 targeted therapy reduces atherosclerosis","volume":"126","author":"Lovren","year":"2012","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"120810","DOI":"10.1016\/j.biomaterials.2021.120810","article-title":"miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype","volume":"273","author":"Chin","year":"2021","journal-title":"Biomaterials."},{"key":"B62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/jmcb\/mjw003","article-title":"Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity","volume":"8","author":"Gast","year":"2016","journal-title":"J Mol Cell Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/cvr\/cvy202","article-title":"Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-\/-mice","volume":"115","author":"Gast","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.029015","article-title":"Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation","volume":"139","author":"Cremer","year":"2019","journal-title":"Circulation."},{"key":"B65","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nm.4479","article-title":"Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA","volume":"24","author":"Sallam","year":"2018","journal-title":"Nat Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1073\/pnas.1432104100","article-title":"RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation","volume":"100","author":"Mazan-Mamczarz","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1038\/s41467-020-19664-2","article-title":"A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus","volume":"11","author":"Simion","year":"2020","journal-title":"Nat Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/01.RES.83.3.270","article-title":"Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability","volume":"83","author":"Fabunmi","year":"1998","journal-title":"Circ Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCRESAHA.116.309321","article-title":"MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin","volume":"120","author":"Di Gregoli","year":"2017","journal-title":"Circ Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1161\/ATVBAHA.118.311298","article-title":"miR-34a promotes vascular smooth muscle cell calcification by downregulating SIRT1(Sirtuin 1) and Axl(AXL Receptor Tyrosine Kinase) arterioscler","volume":"38","author":"Badi","year":"2018","journal-title":"Thromb Vasc Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ymthe.2019.09.008","article-title":"Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis","volume":"28","author":"Xu","year":"2020","journal-title":"Mol Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/cvr\/cvx157","article-title":"miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways","volume":"113","author":"Ceolotto","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"Fernandez-Hernando C, MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J Clin Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","article-title":"Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by Anti-miR33 in atherosclerosis","volume":"117","author":"Karunakaran","year":"2015","journal-title":"Circ Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1172\/JCI81676","article-title":"MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis","volume":"125","author":"Ouimet","year":"2015","journal-title":"J Clin Invest."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","article-title":"Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144","volume":"112","author":"Ramirez","year":"2013","journal-title":"Circ Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","article-title":"MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor","volume":"112","author":"de Aguiar Vallim","year":"2013","journal-title":"Circ Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","article-title":"The long noncoding RNA CHROME regulates cholesterol homeostasis in primate","volume":"1","author":"Hennessy","year":"2019","journal-title":"Nat Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science."},{"key":"B84","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1478","DOI":"10.1002\/wrna.1478","article-title":"A 360 degrees view of circular RNAs: from biogenesis to functions","volume":"9","author":"Wilusz","year":"2018","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"B86","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2019.09.014","article-title":"Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1","volume":"72","author":"Jiang","year":"2020","journal-title":"J Hepatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/cvr\/cvz203","article-title":"Non-coding RNAs in cardiovascular cell biology and atherosclerosis","volume":"115","author":"Fasolo","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/1566523219666190719100526","article-title":"Current RNA-based therapeutics in clinical trials","volume":"19","author":"Zhou","year":"2019","journal-title":"Curr Gene Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tips.2020.08.004","article-title":"Paving the road for RNA therapeutics","volume":"41","author":"Dammes","year":"2020","journal-title":"Trends Pharmacol Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","article-title":"RNA therapeutics in cardiovascular disease","volume":"123","author":"Lucas","year":"2018","journal-title":"Circ Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11427-018-9438-y","article-title":"siRNA therapeutics: a clinical reality","volume":"63","author":"Saw","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/ATVBAHA.111.244053","article-title":"Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium","volume":"32","author":"Fang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCRESAHA.114.302213","article-title":"Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice","volume":"114","author":"Loyer","year":"2014","journal-title":"Circ Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and target derepression of Anti-miR-92a: results of a first in human study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"104653","DOI":"10.1016\/j.phrs.2020.104653","article-title":"Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia","volume":"153","author":"Ruscica","year":"2020","journal-title":"Pharmacol Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N Engl J Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tips.2015.07.001","article-title":"Apolipoprotein C-III. From pathophysiology to pharmacology","volume":"36","author":"Norata","year":"2015","journal-title":"Trends Pharmacol Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Blood","year":"2014","journal-title":"N Engl J Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/eurheartj\/ehz209","article-title":"N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels","volume":"40","author":"Alexander","year":"2019","journal-title":"Eur Heart J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Committees OO, Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"595819","DOI":"10.3389\/fphys.2020.595819","article-title":"PCSK9 inhibition: insights from clinical trials and future prospects","volume":"11","author":"Katzmann","year":"2020","journal-title":"Front Physiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two Phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat Rev Drug Discov."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/cvr\/cvaa047","article-title":"The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis","volume":"116","author":"Zia","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"342ra80","DOI":"10.1126\/scitranslmed.aaf1435","article-title":"Nahrendorf M, RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction","volume":"8","author":"Sager","year":"2016","journal-title":"Sci Transl Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.889743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T06:50:13Z","timestamp":1650869413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.889743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":115,"alternative-id":["10.3389\/fcvm.2022.889743"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.889743","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"889743"}}